Valneva SE (VALN) Long-Term Investments (2020 - 2024)
Valneva SE (VALN) posted Long-Term Investments of $2.4 million for Q1 2022, down 1.89% sequentially from $2.4 million in Q4 2021.
Analysis
Valneva SE (VALN) Long-Term Investments (2020 - 2024) Analysis & Trends
Valneva SE has reported Long-Term Investments for 3 years, with the latest figure at $2.4 million in Q1 2022.
- Quarterly Long-Term Investments changed N/A year-over-year to $2.4 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $2.4 million (changed N/A YoY) and the FY2021 annual result came in at $2.5 million, up 3.35% from the prior year.
- Long-Term Investments declined to $2.4 million in Q1 2022 per VALN's latest filing, from $2.4 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $2.5 million in Q4 2020 and troughed at $2.4 million in Q1 2022.
- A 3-year average of $2.5 million and a median of $2.4 million in 2021 frame the typical range for Long-Term Investments.
- The widest YoY moves for Long-Term Investments: up 4.32% in 2021, down 4.32% in 2021.
- Over 3 years, Long-Term Investments stood at $2.5 million in 2020, then fell by 4.32% to $2.4 million in 2021, then fell by 1.89% to $2.4 million in 2022.
- According to Business Quant data, Long-Term Investments over the past three periods registered $2.4 million, $2.4 million, and $2.5 million for Q1 2022, Q4 2021, and Q4 2020 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -4.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1.77 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.17 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 372.10 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Valneva SE | 578.54 Mn | 437.28 Mn | 1.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 248,197.61 |
| Jun 30, 2024 | 398,448.40 |
| Mar 31, 2024 | 403,040.22 |
| Dec 31, 2023 | 636,956.43 |
| Sep 30, 2023 | 127,365.09 |
| Jun 30, 2023 | 81,669.33 |
| Mar 31, 2023 | 5.38 Mn |
| Dec 31, 2022 | 5.63 Mn |
| Jun 30, 2022 | 3.47 Mn |
| Mar 31, 2022 | 2.38 Mn |
| Dec 31, 2021 | 2.43 Mn |
| Dec 31, 2020 | 2.54 Mn |